PT  - JOURNAL ARTICLE
AU  - Jamil Sadeghifar
AU  - Habib Jalilian
AU  - Khalil Momeni
AU  - Hamed Delam
AU  - Tadesse Sheleme
AU  - Ayoub Rashidi
AU  - Fariba Hemmati
AU  - Shahab Falahi
AU  - Morteza Arab-Zozani
TI  - Evaluation of the disease outcome in Covid-19 infected patients by disease symptoms: a retrospective cross-sectional study in Ilam Province, Iran
AID  - 10.1101/2020.11.10.20228908
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.10.20228908
4099  - http://medrxiv.org/content/early/2020/11/13/2020.11.10.20228908.short
4100  - http://medrxiv.org/content/early/2020/11/13/2020.11.10.20228908.full
AB  - Background novel coronavirus disease-19 (COVID-19) announced as a global pandemic in the year 2020. With the spread of the disease, a better understanding of patient outcomes associated with their symptoms in diverse geographic levels is vital. We aimed to analysis clinical outcomes of COVID-19 patients by disease symptoms in Ilam province of Iran.Methods This is a retrospective study. Data were collected from integrated health system records for all hospitals affiliated to Ilam University of Medical Sciences between 26 Jan 2020 and 02 May 2020. All patients with definite positive test were enrolled in this study. We used descriptive analyses, chi-square test and binary logistic regression to analyze the data using SPSS version 22.Results The mean age was 46.47±18.24 years. Of 3608 patients, 3477 (96.1%) were discharged and 129 (3.9%) were died. 54.2% of the patients were male and were in the age group of 30-40 years old age. Cough, sore throat, shortness of breath or difficulty breathing and fever or chills were the most common symptoms. People with symptoms of shortness of breath, abnormal radiographic findings of the chest, and chest pain and pressure were relatively more likely to die. Based on the findings of binary logistic regression probability of death in people who showed shortness of breath, abnormal chest radiographic findings and chest pain was 1.34, 1.24 and 1.32 times higher than those who did not show these symptoms, respectively.Conclusion Our study provides evidence that presentation of some symptoms does significantly impact on outcomes of patients infected with SARS-CoV-2. Early detection of symptoms and proper management of outcomes can reduce mortality in patients with COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ilam University of Medical Sciences (No. IR.MEDILAM.REC.1399.043).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available in case of request.SARS-COV-2severe acute respiratory syndrome coronavirus 2COVID-19novel Coronavirus disease 2019RT-PCRreal-time reverse transcriptase–polymerase chain reactionWHOWorld Health OrganizationICUintensive care unit